Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,518.47 100.94 0.70%
TOPIX 1,171.08 4.49 0.38%
HANG SENG 22,760.24 64.23 0.28%

Investor Alert: Holzer Holzer & Fistel, LLC Reminds Investors of Upcoming Deadlines in Shareholder Litigation Involving Aveo


Investor Alert: Holzer Holzer & Fistel, LLC Reminds Investors of Upcoming Deadlines in Shareholder Litigation Involving Aveo Pharmaceuticals Inc. and Vitamin Shoppe Inc.

ATLANTA, GA -- (Marketwired) -- 06/24/13 -- Holzer Holzer & Fistel, LLC reminds investors of upcoming deadlines for applications to serve as lead plaintiff in securities class action lawsuits against Aveo Pharmaceuticals Inc. (AVEO) and Vitamin Shoppe Inc. (VSI).

Investors that suffered significant losses investing in either of these companies during the specified times who are interested in potentially serving as lead plaintiff in the respective class actions are encouraged to contact Michael I. Fistel, Jr., Esq. (mfistel@holzerlaw.com) or Marshall P. Dees, Esq. (mdees@holzerlaw.com) by email or via toll-free telephone at (888) 508-6832 to discuss their legal rights.

A lead plaintiff is a representative party appointed by the court to act on behalf of other class members in directing the litigation. Any member of the purported class may move the court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.

Aveo Pharmaceuticals Inc.

A class action lawsuit has been filed on behalf of investors who purchased Aveo Pharmaceuticals (NASDAQ: AVEO) common stock between January 3, 2012 and May 1, 2013. The complaint alleges that during the relevant time period AVEO violated the federal securities laws by issuing misleading statements about the effectiveness of Tivopath (or tivozanib) in the treatment of renal cell carcarcinoma.

The deadline to seek appointment as lead plaintiff in this lawsuit, which is pending in the United States District Court for the District of Massachusetts, is July 8, 2013. More information about the lawsuit and the firm are available at www.holzerlaw.com.

Vitamin Shoppe Inc.

A class action lawsuit has been filed on behalf of investors who purchased Vitamin Shoppe Inc. (NYSE: VSI) common stock between May 8, 2012 and February 25, 2013, inclusive. The complaint alleges that during that time Vitamin Shoppe issued false and misleading statements to investors regarding competition from online retailers and sales trends for its products.

The deadline to seek appointment as lead plaintiff in this lawsuit, which is pending in the United States District Court for the District of New Jersey, is July 8, 2013. More information about the lawsuit and the firm are available at www.holzerlaw.com.

About The Firm

Holzer Holzer & Fistel, LLC dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. More information about the firm is available through its website www.holzerlaw.com and upon request from the firm. Holzer Holzer & Fistel, LLC has paid for the dissemination of this promotional communication, and Michael I. Fistel, Jr. is the attorney responsible for its content.

CONTACT:

Michael I. Fistel, Jr., Esq. Marshall P. Dees, Esq. Holzer Holzer & Fistel, LLC 200 Ashford Center North, Suite 300 Atlanta, GA 30338 (888) 508-6832 (toll-free) mfistel@holzerlaw.commdees@holzerlaw.com

Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement